日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real‐world analysis from 20 US centers

纳武利尤单抗联合AVD方案作为经典型霍奇金淋巴瘤患者的一线治疗:来自美国20个中心的真实世界分析

Quinquenel, Anne; Aurran-Schleinitz, Thérèse; Clavert, Aline; Cymbalista, Florence; Dartigeas, Caroline; Davi, Frédéric; de Guibert, Sophie; Delmer, Alain; Dilhuydy, Marie-Sarah; Feugier, Pierre; Fornecker, Luc-Matthieu; Ghez, David; Guieze, Romain; Laribi, Kamel; Leblond, Véronique; Leprêtre, Stéphane; Letestu, Rémi; Lévy, Vincent; Nguyen-Khac, Florence; Michallet, Anne-Sophie; Tomowiak, Cécile; Tournilhac, Olivier; Ysebaert, Loïc; Troussard, Xavier; Bock, Allison M; Hao, Peirong; Xu, Yizhe; Luttwak, Efrat; Thiruvengadam, Swetha Kambhampati; Sekaran, Kanithra; Sano, Dahlia; Vaughn, John; Sharp, John; Major, Ajay; Patel, Vrutti; Smilnak, Gordon; Araujo, Nicole; Mynam, Ritwick; Reef, Daniel; Palmeri, Marisa; Gerber, Drew; Abhyankar, Anuja; Baek, Grace; Falade, Ayo; Iqbal, Madiha; Hu, Boyu; Geethakumari, Praveen Ramakrishnan; Durani, Urshila; Di, Mengyang; Niu, Alex; Cherng, Hua‐Jay J; Rhodes, Joanna M; Grover, Natalie; Pophali, Priyanka; Feldman, Tatyana; Shanmugasundaram, Krithika; Svoboda, Jakub; Voorhees, Timothy; Diefenbach, Catherine; Karimi, Yasmin; Karmali, Reem; Herrera, Alex F; Torka, Pallawi; Epperla, Narendranath

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group

在既往未接受治疗的中危慢性淋巴细胞白血病患者中,以可测量的残余病灶为指导,比较伊布替尼联合维奈克拉与FCR方案的疗效:一项来自FILO组的II期随机试验(ERADIC)。

Quinquenel, Anne; Letestu, Rémi; Le Garff-Tavernier, Magali; Morisset, Stéphane; Subtil, Fabien; Aurran, Thérèse; Laribi, Kamel; Cymbalista, Florence; Lévy, Vincent; Simon, Laurence; Roos-Weil, Damien; Leblond, Véronique; Dilhuydy, Marie-Sarah; Tomowiak, Cécile; Dartigeas, Caroline; Guièze, Romain; Tournilhac, Olivier; Ferrant, Emmanuelle; de Guibert, Sophie; Feugier, Pierre; Merabet, Fatiha; Leprêtre, Stéphane; Carassou, Philippe; Gay, Julie; Hivert, Bénédicte; Fornecker, Luc-Matthieu; Dupuis, Jehan; Molina, Lysiane; Villemagne, Bruno; Cartron, Guillaume; Drenou, Bernard; Mahé, Beatrice; Benbrahim, Omar; Cahu, Xavier; Portois, Christelle; Ysebaert, Loïc; Nguyen-Khac, Florence; Dahmani, Abdelmalek; Quiney, Claire; Rouillé, Valérie; Delmer, Alain; Michallet, Anne-Sophie

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL

检测TP53基因中等位基因频率低于10%的临床相关变异:欧洲慢性淋巴细胞白血病研究计划(ERIC)的一项多中心研究

Pavlova, Sarka; Malcikova, Jitka; Radova, Lenka; Bonfiglio, Silvia; Cowland, Jack B; Brieghel, Christian; Andersen, Mette K; Karypidou, Maria; Biderman, Bella; Doubek, Michael; Lazarian, Gregory; Rapado, Inmaculada; Vynck, Matthijs; Porret, Naomi A; Andres, Martin; Rosenberg, Dina; Sahar, Dvora; Martínez-Laperche, Carolina; Buño, Ismael; Hindley, Andrew; Donaldson, David; Sánchez, Julio B; García-Marco, José A; Serrano-Alcalá, Alicia; Ferrer-Lores, Blanca; Fernández-Rodriguez, Concepción; Bellosillo, Beatriz; Stilgenbauer, Stephan; Tausch, Eugen; Nikdin, Hero; Quinn, Fiona; Atkinson, Emer; van de Corput, Lisette; Yildiz, Cafer; Bilbao-Sieyro, Cristina; Florido, Yanira; Thiede, Christian; Schuster, Caroline; Stoj, Anastazja; Czekalska, Sylwia; Chatzidimitriou, Anastasia; Laidou, Stamatia; Bidet, Audrey; Dussiau, Charles; Nollet, Friedel; Piras, Giovanna; Monne, Maria; Smirnova, Svetlana; Nikitin, Eugene; Sloma, Ivan; Claudel, Alexis; Largeaud, Laetitia; Ysebaert, Loïc; Valk, Peter J M; Christian, Amy; Walewska, Renata; Oscier, David; Sebastião, Marta; da Silva, Maria Gomes; Galieni, Piero; Angelini, Mario; Rossi, Davide; Spina, Valeria; Matos, Sónia; Martins, Vânia; Stokłosa, Tomasz; Pepek, Monika; Baliakas, Panagiotis; Andreu, Rafa; Luna, Irene; Kahre, Tiina; Murumets, Ülle; Pikousova, Tereza; Kurucova, Terezia; Laird, Sophie; Ward, Daniel; Alcoceba, Miguel; Balanzategui, Ana; Scarfo, Lydia; Gandini, Francesca; Zapparoli, Ettore; Blanco, Adoración; Abrisqueta, Pau; Rodríguez-Vicente, Ana E; Benito, Rocío; Bravetti, Clotilde; Davi, Frédéric; Gameiro, Paula; Martinez-Lopez, Joaquin; Tazón-Vega, Bárbara; Baran-Marszak, Fanny; Davis, Zadie; Catherwood, Mark; Sudarikov, Andrey; Rosenquist, Richard; Niemann, Carsten U; Stamatopoulos, Kostas; Ghia, Paolo; Pospisilova, Sarka

Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population

一线持续伊布替尼治疗和固定疗程伊布替尼-维奈克拉治疗慢性淋巴细胞白血病患者的总生存期结果:与年龄匹配的欧洲人群的比较

Ghia, Paolo; Ysebaert, Loic; Janssens, Ann; Stilgenbauer, Stephan; Fouad, Mohamed; Schioppa, Claudio A; Hernández-Rivas, José-Ángel; Tedeschi, Alessandra

Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA

tazemetostat联合R-CHOP方案治疗新诊断为弥漫性大B细胞淋巴瘤的老年患者的疗效:LYSA研究的EpiRCHOP II期研究结果

Sarkozy, Clémentine; Molina, Thierry Jo; Dubois, Sydney; Portugues, Cédric; Bohers, Elodie; Ysebaert, Loic; Houot, Roch; Pica, Gian Matteo; Ruminy, Philippe; Herbaux, Charles; Gastinne, Thomas; Thieblemont, Catherine; Haioun, Corinne; Guidez, Stéphanie; Bonnet, Christophe; Crochet, Gilles; Veresezan, Liana; Choquet, Sylvain; Bachy, Emmanuel; Jardin, Fabrice; Morschhauser, Franck; Ribrag, Vincent

Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy

慢性淋巴细胞白血病细胞中CD69、CD49d、CD279和CD20的共表达是治疗前或治疗期间疾病活动性的新型生物标志物。

Cadot, Sarah; Ysebaert, Loïc; Lamy, Sébastien; Laurent, Camille; Quillet-Mary, Anne

The CLL hunters: finally, BTK got arrested

CLL 猎杀者:BTK 终于被捕了

Ysebaert, Loic

Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group

阿特珠单抗、奥妥珠单抗和维奈托克治疗复发/难治性B细胞非霍奇金淋巴瘤患者:LYSA研究组II期试验的最终分析

Herbaux, Charles; Bachy, Emmanuel; Bouabdallah, Reda; Guidez, Stéphanie; Casasnovas, Olivier; Feugier, Pierre; Damaj, Gandhi; Tilly, Hervé; Ysebaert, Loïc; Le Gouill, Steven; Morineau, Nadine; Gyan, Emmanuel; Gressin, Rémy; Houot, Roch; Cheminant, Morgane; Morschhauser, Franck; Thieblemont, Catherine; Haioun, Corinne; Nicolas-Virelizier, Emmanuelle; Fornecker, Luc-Matthieu; Daguindau, Nicolas; Cartron, Guillaume

Comparing the diagnostic accuracy of pre-operative genetic testing for thyroid cancer on fine needle aspiration cytology specimens: a systematic review and meta-analysis of diagnostic accuracy

比较术前基因检测对甲状腺癌细针穿刺细胞学标本诊断准确性的系统评价和荟萃分析

Liao, Xin; Van Den Heede, Klaas; Lapauw, Bruno; Huvenne, Wouter; Ysebaert, Dirk; Meert, Vanessa; Fang, Ying; Li, Jing; Van Slycke, Sam; Brusselaers, Nele

Pivotal role for typing of renal infiltrates: kidney localisation of a lymphoma presenting as pembrolizumab-associated nephritis. A lesson for the clinical nephrologist

肾脏浸润分型的关键作用:淋巴瘤肾脏定位表现为帕博利珠单抗相关性肾炎。对临床肾脏科医生的启示

Benyahia, Rayane; Roques, Olivier; Ysebaert, Loïc; Bergé, Yann; Mazières, Julien; Syrykh, Charlotte; Colombat, Magali; Belliere, Julie